+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intraocular Lens (IOL) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 129 Pages
  • November 2021
  • Region: Global
  • GlobalData
  • ID: 5505132
The publisher's Medical Devices sector report, “Intraocular Lens (IOL) - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Intraocular Lens (IOL) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Intraocular lens is an artificial lens made of plastic, silicone, acrylic or other material that is implanted inside the eye during cataract surgery. Foldable (phakic) IOL and Polymethyl Methacrylate (PMMA) IOL are tracked under this category.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Intraocular Lens (IOL) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intraocular Lens (IOL) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Intraocular Lens (IOL) Overview
3 Products under Development
3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
3.2 Intraocular Lens (IOL) - Pipeline Products by Segment
3.3 Intraocular Lens (IOL) - Pipeline Products by Territory
3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials
4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies
4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development
5 Intraocular Lens (IOL) Companies and Product Overview
6 Intraocular Lens (IOL)- Recent Developments
6.1 Nov 02, 2021: Bausch Health Companies Announces Third-Quarter 2021 Results
6.2 Sep 29, 2021: Bausch Health Releases Annual Environmental, Social and Governance Report
6.3 Aug 10, 2021: RxSight Announces Appointments to its Board of Directors
6.4 Aug 03, 2021: Bausch Health Announces Second-Quarter 2021 Results
6.5 Jul 21, 2021: STAAR Surgical to Report Second Quarter Results on August 4, 2021
6.6 Jul 12, 2021: Bausch + Lomb launches Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelid Cleansing Wipes
6.7 Jul 06, 2021: Bausch Health Companies Will Release Second-Quarter 2021 Financial Results On August 3
6.8 May 11, 2021: Santen Reports Fiscal 2020 Consolidated Financial Results for the Year Ended March 31, 2021
6.9 May 04, 2021: Bausch Health Companies Announces First-Quarter 2021 Results
6.10 Apr 28, 2021: Bausch Health Announces 2021 Annual Meeting of Shareholder Results
6.11 Apr 21, 2021: STAAR Surgical to Report First Quarter Results on May 5, 2021
6.12 Apr 09, 2021: Santen Pharmaceutical Notice of Recording of Impairment Loss and Revision of Full-Year Earnings Forecasts
6.13 Apr 09, 2021: Bausch Health will Release First-Quarter 2021 Financial Results on May 4, 2021
6.14 Mar 22, 2021: SIFI announces granting of marketing authorizations in Turkey
6.15 Mar 09, 2021: Bausch Health Publishes Pipeline Update For The Barclays Global Healthcare Conference
6.16 Feb 24, 2021: 02.24.2021 STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results
6.17 Feb 10, 2021: STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021
6.18 Jan 27, 2021: Bausch Health Will Release Fourth-Quarter And Full-Year 2020 Financial Results On February 24
6.19 Jan 19, 2021: New Nd: YAG doublets eliminate chromatic aberration, and LT series lenses achieve autofocus for 1.1 sensors
6.20 Jan 15, 2021: Human Optics AG appointed Stefan Kremer as new Chief Executive Officer (CEO)
6.21 Jan 08, 2021: Santen to Hold a Presentation for the 39th Annual J.P. Morgan Healthcare Conference
6.22 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings
6.23 Dec 01, 2020: Oxford Finance closes $60 million credit facility with RxSight
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
List of Tables
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Segment
Intraocular Lens (IOL) - Pipeline Products by Territory
Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Intraocular Lens (IOL) - Ongoing Clinical Trials
Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Glossary
List of Figures
Intraocular Lens (IOL) - Pipeline Products by Stage of Development
Intraocular Lens (IOL) - Pipeline Products by Segment
Intraocular Lens (IOL) - Pipeline Products by Territory
Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
Intraocular Lens (IOL) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AcuFocus Inc
  • Adaptilens LLC
  • Adoptics AG (Inactive)
  • AkkoLens International BV
  • Alcon Inc
  • Anew Optics, Inc.
  • Atia Vision Inc
  • Bausch & Lomb Inc
  • Care Group
  • Clarvista Medical Inc
  • ClearSight LLC
  • Elenza, Inc.
  • Emmetrope Incorporated
  • EyeKon Medical Inc
  • Hoya Surgical Optics Inc
  • InnFocus Inc
  • Innovia LLC
  • Johnson & Johnson Vision Care Inc
  • LensGen Inc
  • Lenstec Inc
  • London Eye Hospital
  • Medicontur Medical Engineering Ltd
  • Meir Medical Center
  • Morcher Gmbh
  • Nayam Innovations Pvt Ltd
  • Nidek Co Ltd
  • Northwestern University
  • NuLens Ltd. (Inactive)
  • Ocumetics Technology Corp
  • PhysIOL SA
  • Presbeasy
  • Rayner Intraocular Lenses Ltd
  • Sav-Iol SA
  • STAAR Surgical Company
  • Strathspey Crown LLC
  • University of East Anglia
  • University of Rochester
  • University of Tampere
  • Visidome Ltd
  • Visioneering Technologies Inc
  • VisusNano Labs
  • VSY Biotechnology BV
  • Washington University in St Louis
  • Xend
  • Z Lens LLC